Baudax Bio, Inc.
BXRXDelisted Feb 15, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001780097
Baudax Bio, Inc. was delisted on Feb 15, 2024; its insiders filed their last Form 4 on Dec 19, 2022; 15 institutions reported holding it in 13F filings for Q3 2023, worth $74.5K in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Baudax Bio, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- 0 vs. Q2 2022
- Shares held
- 1.43M
- +157.7K (+12.4%) vs. Q2 2022
- Total value
- $352.0K
- −$727.0K (−67.4%) vs. Q2 2022
- New holders
- 6
- 6 more added
- Sold out
- 6
- 4 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BXRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 1 | $0 |
| Q2 2024 | 1 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 2 | $0 |
| Q3 2023 | 15 | $74.5K |
| Q2 2023 | 12 | $152.0K |
| Q1 2023 | 12 | $127.0K |
| Q4 2022 | 10 | $73.2K |
| Q3 2022 | 22 | $352.0K |
| Q2 2022 | 22 | $1.08M |
| Q1 2022 | 21 | $2.20M |
| Q4 2021 | 33 | $2.78M |
| Q3 2021 | 31 | $4.12M |
| Q2 2021 | 39 | $5.58M |
| Q1 2021 | 38 | $9.43M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Baudax Bio, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sabby Management, LLC | 439,220 | $108.0K | 0.23% | +392,103+832.2% | Added |
| Warberg Asset Management LLC | 270,000 | $66.0K | 0.02% | +235,500+682.6% | Added |
| Renaissance Technologies LLC | 241,523 | $59.0K | 0.00% | −78,647−24.6% | Reduced |
| Virtu Financial LLC | 108,332 | $27.0K | 0.00% | +87,828+428.3% | Added |
| UBS Group AG | 77,343 | $19.0K | 0.00% | +70,208+984.0% | Added |
| Geode Capital Management, LLC | 65,577 | $16.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 58,320 | $14.0K | 0.00% | −1,061−1.8% | Reduced |
| Susquehanna International Group, LLP | 48,521 | $12.0K | 0.00% | +48,521 | New |
| Two Sigma Securities, LLC | 40,552 | $10.0K | 0.00% | +40,552 | New |
| BlackRock Inc. | 31,916 | $8.00K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 25,904 | $6.00K | 0.00% | +25,904 | New |
| Dynamic Advisor Solutions LLC | 11,000 | $3.00K | 0.00% | +11,000 | New |
| Tower Research Capital LLC (TRC) | 6,546 | $2.00K | 0.00% | −468−6.7% | Reduced |
| Morgan Stanley | 5,386 | $1.00K | 0.00% | +4,526+526.3% | Added |
| Edmond de Rothschild Holding S.A. | 2,857 | $1.00K | 0.00% | +2,857 | New |
| Advisor Group Holdings, Inc. | 942 | $0 | 0.00% | −258−21.5% | Reduced |
| JPMorgan Chase & Co | 14 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 56 | $0 | 0.00% | +11+24.4% | Added |
| Group One Trading, L.P. | 213 | $0 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 14 | $0 | 0.00% | 00.0% | Unchanged |
| Sittner & Nelson, LLC | 45 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 582 | $0 | 0.00% | +582 | New |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −460,000−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −195,095−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −23,323−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −2,966−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |